Agilon Health Net Worth
Agilon Health Net Worth Breakdown | AGL |
Agilon Health Net Worth Analysis
Agilon Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Agilon Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Agilon Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Agilon Health's net worth analysis. One common approach is to calculate Agilon Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Agilon Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Agilon Health's net worth. This approach calculates the present value of Agilon Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Agilon Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Agilon Health's net worth. This involves comparing Agilon Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Agilon Health's net worth relative to its peers.
To determine if Agilon Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Agilon Health's net worth research are outlined below:
| agilon health had very high historical volatility over the last 90 days | |
| The company reported the last year's revenue of 4.32 B. Reported Net Loss for the year was (262.8 M) with loss before taxes, overhead, and interest of (51.77 M). | |
| agilon health has about 497.07 M in cash with (156.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.32. | |
| Over 98.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: agilon health Trading Up 8.5 percent Following Analyst Upgrade - MarketBeat |
Agilon Health Quarterly Good Will |
|
Agilon Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in agilon health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Agilon Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 6th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Agilon Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Agilon Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading agilon health backward and forwards among themselves. Agilon Health's institutional investor refers to the entity that pools money to purchase Agilon Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Goldman Sachs Group Inc | 2024-09-30 | 5.7 M | Bank Of America Corp | 2024-09-30 | 5 M | Charles Schwab Investment Management Inc | 2024-09-30 | 3 M | Northern Trust Corp | 2024-09-30 | 2.6 M | Millennium Management Llc | 2024-09-30 | 2.5 M | Citadel Advisors Llc | 2024-09-30 | 2.1 M | Deutsche Bank Ag | 2024-09-30 | 2.1 M | Citigroup Inc | 2024-09-30 | 2 M | Nuveen Asset Management, Llc | 2024-09-30 | 1.8 M | Clayton Dubilier & Rice Llc | 2024-09-30 | 100 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 56.2 M |
Follow Agilon Health's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 1.27 B.Market Cap |
|
Project Agilon Health's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.14) | (0.15) | |
| Return On Capital Employed | (0.27) | (0.29) | |
| Return On Assets | (0.15) | (0.14) | |
| Return On Equity | (0.46) | (0.43) |
When accessing Agilon Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Agilon Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Agilon Health's profitability and make more informed investment decisions.
Evaluate Agilon Health's management efficiency
agilon health has Return on Asset of (0.0984) % which means that on every $100 spent on assets, it lost $0.0984. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.43) %, meaning that it generated no profit with money invested by stockholders. Agilon Health's management efficiency ratios could be used to measure how well Agilon Health manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.15. The value of Return On Capital Employed is expected to slide to -0.29. Net Tangible Assets is expected to rise to about 1.1 B this year, although the value of Total Assets will most likely fall to about 1.3 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.45 | 0.89 | |
| Tangible Book Value Per Share | 1.26 | 0.69 | |
| Enterprise Value Over EBITDA | (27.25) | (28.62) | |
| Price Book Value Ratio | 6.98 | 7.33 | |
| Enterprise Value Multiple | (27.25) | (28.62) | |
| Price Fair Value | 6.98 | 7.33 |
At agilon health, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Enterprise Value Revenue 0.1652 | Revenue | Quarterly Revenue Growth 0.276 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Agilon Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Agilon Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Agilon Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Agilon Health Corporate Filings
F4 | 20th of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 6th of December 2024 Other Reports | ViewVerify | |
8K | 5th of December 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 13th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Agilon Health Earnings per Share Projection vs Actual
Agilon Health Corporate Management
| Timothy Gertsch | Controller VP | Profile | |
| Benjamin Shaker | Chief Officer | Profile | |
| Bill Farry | Chief Innovation | Profile | |
| Derek Strum | Director | Profile | |
| Michelle Gourdine | Independent Director | Profile | |
| Denise Zamore | Chief Secretary | Profile |
Already Invested in agilon health?
The danger of trading agilon health is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Agilon Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Agilon Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile agilon health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether agilon health is a strong investment it is important to analyze Agilon Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Agilon Health's future performance. For an informed investment choice regarding Agilon Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in agilon health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.951 | Earnings Share (0.76) | Revenue Per Share | Quarterly Revenue Growth 0.276 | Return On Assets |
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.